Revenue
No reported data
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Research & development | $1.1M | $992,000 | $1.6M | $9.0M | $5.9M | $99,580 | $897,788 | $708,455 |
| Operating expenses | — | $4.4M | $11.8M | $15.5M | $11.9M | $2.3M | $4.2M | $3.4M |
| Operating income | −$2.6M | −$2.1M | −$3.0M | −$15.5M | −$11.9M | −$2.3M | −$4.2M | −$3.4M |
| EBITDAderived | −$2.5M | −$1.7M | −$2.4M | — | — | — | — | — |
| Net income | −$8.3M | −$7.2M | −$3.3M | −$16.5M | −$11.9M | −$2.9M | −$5.4M | −$5.1M |
| Basic EPSper diluted share | $2.16 | $2.43 | $1.13 | -$33.52 | -$1.00 | -$0.41 | — | — |
| Diluted EPSper diluted share | $2.16 | $2.43 | $1.13 | -$33.52 | -$1.00 | -$0.41 | — | — |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 27, 2026Form 4 | Samuel OlivierDirector | BuyCommon Shares, par value CHF 0.05 per share | 81.8K | $2.75 | $225.0K | 81.8K |
| Apr 27, 2026Form 4 | Samuel OlivierDirector | BuyWarrant (right to buy) · derivative | 114.5K | — | — | 114.5K |
| Apr 27, 2026Form 4 | Revel MichelCSO and Director | BuyCommon Shares, par value CHF 0.05 per share | 54.5K | $2.75 | $150.0K | 957.5K |
| Apr 27, 2026Form 4 | Revel MichelCSO and Director | BuyWarrant (right to buy) · derivative | 76.4K | — | — | 76.4K |